AtendimentoFavoritos
Acessar conta
Carrinho0

Meu Carrinho

    Total

    Finalização da Compra
    Buscar
    Anavex Life Sciences
    Cód:
    491_9785510811858
    High Quality Content by WIKIPEDIA articles! Anavex Life Sciences Corp. is a biopharmaceutical company engaged in the discovery and development of new drugs for the treatment of neurological diseases and cancer, utilizing its proprietary drug discovery SIGMACEPTOR(tm) platform. The Anavex portfolio comprises novel, wholly owned sigma receptor agonists and antagonists. The companys lead drug candidate for Alzheimers disease (AD), ANAVEX 2-73, is in Phase 1 clinical trials, getting assessed for its safety, maximally tolerated dose, pharmacokinetics and pharmacodynamics. The company has also started scale-up manufacturing for ANAVEX 1-41, its second lead compound, targeting depression and AD. With sufficient quantities of ANAVEX 1-41 in hand, the company will be in a position to advance the program and begin preclinical studies on large animals in the near term.
    Veja mais

    Quem comprou também comprou

    Quem viu também comprou

    Quem viu também viu